Breadcrumb

CORE News

New study of therapy options in metastatic melanoma

RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors

Nip it in the bud: New study will attack SARS-Cov2 where it multiplies

RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening

Serious Flaws in Studies Linking COVID-19 and Air Pollution

Studies have yet to prove this link, say Carleton and McGill University epidemiologists

Systematic testing of groups at increased risk of SARS-CoV-2: an affordable and reasonable approach

In a new cost-analysis study, researchers recommend widespread testing of...

Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19

Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations

COVID-19 Q&A on dealing with pandemic fatigue

“We need to strike a balance and take our anxiety down from an unhealthy to a manageable level,” says researcher Jason Harley

New study shows that persistence of ADHD into adulthood is an important predictor of car crash risk

RI-MUHC researcher Dr. Lily Hechtman is senior author of a 20-year study

Lashanda Skerritt awarded Vanier Canada Graduate Scholarship

“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...

Research suggests greater access to specific HIV and tuberculosis medications is needed worldwide

Postdoctoral fellows at the RI-MUHC carried out primary statistical analyses for study published in The Lancet

Inappropriate prescriptions sending hospitalized seniors back to the ER

Improving hospital prescribing practices may reduce risk of rehospitalization and death

Explore news and events at the RI-MUHC